T-cell immunity against tumors, a delicate balancing act involving dendritic cellsMELIEF, C. J. M.Pathologie et biologie. 2001, Vol 49, Num 6, pp 498-499, issn 0369-8114Conference Paper

Prospects of T-cell immunotherapy for cancer by peptide vaccinationMELIEF, C. J. M.Seminars in hematology. 1993, Vol 30, Num 3, pp 32-33, issn 0037-1963, SUP3Conference Paper

Dendritic cells as specialized antigen-presenting cellsMELIEF, C. J. M.Research in immunology. 1989, Vol 140, Num 9, pp 902-906Conference Paper

Tumor eradication by adoptive transfer of cytotoxic T lymphocytesMELIEF, C. J. M.Advances in cancer research. 1992, Vol 58, pp 143-175, issn 0065-230XArticle

Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumours and peptide-MHC bindingKAST, W. M; MELIEF, C. J. M.International journal of cancer. 1991, pp 90-94, issn 0020-7136, SUP6Article

Virology, genetics and immunology of murine lymphomagenesisZIJLSTRA, M; MELIEF, C. J. M.Biochimica et biophysica acta. 1986, Vol 865, Num 2, pp 197-231, issn 0006-3002Article

Identification of t-cell epitopes for cancer immunotherapyKESSLER, J. H; MELIEF, C. J. M.Leukemia. 2007, Vol 21, Num 9, pp 1859-1874, issn 0887-6924, 16 p.Article

Immunobiology of the expanded T cells in T-Cell leukemia and T-gamma lymphocytosisMIEDEMA, F; MELIEF, C. J. M.Leukemia research. 1986, Vol 10, Num 5, pp 469-474, issn 0145-2126Article

T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopesMELIEF, C. J. M; KAST, W. M.Immunological reviews. 1995, Vol 145, pp 167-177, issn 0105-2896Article

Transmission of lymphotropic retroviruses (HTLV-1 and LAV/HTLV-III) by blood transfusion and blood productsMELIEF, C. J. M; GOUDSMIT, J.Vox sanguinis (Basel. 1956). 1986, Vol 50, Num 1, pp 1-11, issn 0042-9007Article

Cd80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigensMUTIS, T; SCHRAMA, E; MELIEF, C. J. M et al.Blood. 1998, Vol 92, Num 5, pp 1677-1684, issn 0006-4971Article

Differences in oncogenicity among murine leukemia virus isolates are not correlated with the magnitude of H-2 regulated anti-viral envelope antibody responsesZIJLSTRA, M; SCHOENMAKERS, H. J; MELIEF, C. J. M et al.Leukemia research. 1986, Vol 10, Num 9, pp 1121-1129, issn 0145-2126Article

Mutations in the major histocompatibility complex class I antigen-presenting groove affect both negative and positive selection of T cellsJACOBS, H; VON BOEHMER, H; MELIEF, C. J. M et al.European journal of immunology. 1990, Vol 20, Num 10, pp 2333-2337, issn 0014-2980, 5 p.Article

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cellsMARTIN KAST, W; DE WAAL, L. P; MELIEF, C. J. M et al.The Journal of experimental medicine. 1984, Vol 160, Num 6, pp 1752-1766, issn 0022-1007Article

Direct demonstration that cytotoxic T lymphocytes recognize conformational determinants and not primary amino acid sequencesDE WAAL, L. P; NATHENSON, S. G; MELIEF, C. J. M et al.The Journal of experimental medicine. 1983, Vol 158, Num 5, pp 1720-1726, issn 0022-1007Article

Stimulation with dendritic cells decreases or obviates the CD4⁺ helper cell requirement in cytotoxic T lymphocyte responseBOOG, C. J. P; BOES, J; MELIEF, C. J. M et al.European journal of immunology. 1988, Vol 18, Num 2, pp 219-223, issn 0014-2980, 5 p.Article

Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responsesBOOG, C. J. P; BOES, J; MELIEF, C. J. M et al.The Journal of immunology (1950). 1988, Vol 140, Num 10, pp 3331-3337, issn 0022-1767Article

Recognition of H-2K^b mutant target cells by Moloney virus specific cytotoxic T lymphocytes from bm13 (H-2D^b mutant) mice. I: Full recognition of K^bm11 by K^b-restricted CTL = Reconnaissance des cellules cibles mutantes H-2 Kb par les lymphocytes T cytoxiques du virus de Moloney provenant de souris bm 13 (mutantes H-2Db). I. Reconnaissance complète de Kbm11 par les CTL Kb-restreintesSTUKART, M. J; BOES, J; MELIEF, C. J. M et al.The Journal of immunology (1950). 1984, Vol 133, Num 1, pp 24-27, issn 0022-1767Article

Recognition of H-2K^b mutant target cells by Moloney virus specific cytotoxic T lymphocytes from bm13 (H-2D^b-mutant) mice. II: Relationship of K^bm3 and K^bm11 in restriction specificities and allodeterminants = Reconnaissance des cellules cibles mutantes H-2 Kb par les lymphocytes T cytotoxiques spécifiques du virus de Moloney, provenant de souris bm13 (mutantes H-2Db). II. Relation de Kbm3 et de Kbm11 dans les spécificités de restriction et les allodéterminantsSTUKART, M. J; BOES, J; MELIEF, C. J. M et al.The Journal of immunology (1950). 1984, Vol 133, Num 1, pp 28-32, issn 0022-1767Article

Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2D^b mutants bm13 and bm14. Complementation of the response in F₁ crosses with the I-A^b mutant bm12 nonresponder and failure of B6 or D^b mutant mice tolerant of each other to respond to allogeneic male cellsDE WAAL, L. P; MELVOLD, R. W; MELIEF, C. J. M et al.The Journal of experimental medicine. 1983, Vol 158, Num 5, pp 1537-1546, issn 0022-1007Article

T-cell immunotherapy of cancerMELIEF, C. J. M; KAST, W. M.Research in immunology (Paris). 1991, Vol 142, Num 5-6, pp 425-429, issn 0923-2494Conference Paper

Persistance of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host diseaseROZENDAAL, L; PALS, S. T; GLEICHMANN, E et al.Clinical and experimental immunology (Print). 1990, Vol 82, Num 3, pp 527-532, issn 0009-9104, 6 p.Article

Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccinationKAST, W. M; BRANDT, R. M. P; MELIEF, C. J. M et al.European journal of immunology. 1993, Vol 23, Num 5, pp 1189-1192, issn 0014-2980Article

Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2KAST, W. M; BRANDT, R. M. P; DRIJFHOUT, J. W et al.Journal of immunotherapy. 1993, Vol 14, Num 2, pp 115-120, issn 1053-8550Conference Paper

Protection from lethal graft-vs.-host disease by donor stem cell repopulationROZENDAAL, L; PALS, S. T; MELIEF, C. J. M et al.European journal of immunology. 1992, Vol 22, Num 2, pp 575-579, issn 0014-2980Article